NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) Total Debt (2018 - 2023)

Updated

NovaBridge Biosciences (NBP) posted Total Debt of $4.22 million for Q4 2023, up 54.9% from $2.72 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) Total Debt (2018 - 2023) Analysis & Trends

Since Q4 2018, NovaBridge Biosciences has reported Total Debt for 5 quarters.

  • Annual Total Debt shows a five-year compound annual growth rate of -18.4% (FY2018 to FY2023).
  • In prior years, NovaBridge Biosciences' Total Debt was $2.75 million in FY2022 and $7.18 million in FY2019 (-38.3%).
  • The Q4 2023 figure stands as the highest quarterly Total Debt since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 4.22 Mn
Jun 30, 2023 4.13 Mn
Dec 31, 2022 2.72 Mn
Dec 31, 2019 7.16 Mn
Dec 31, 2018 11.63 Mn
API Access

NovaBridge Biosciences Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=NBP&period=max&api_key=YOUR_API_KEY